Overall, tirzepatide was found to effectively improve glycemic control and reduce body weight, making it a promising treatment option for type 2 diabetes
Sahlin, Kent
Decisions regarding medications, supplements, or changes to diet and physical activity should be made in consultation with a qualified healthcare provider who is familiar with your individual medical history and health needs
Taking into account the above-mentioned considerations on cost and safety aspects, oral small molecule agonists stimulating endogenous GLP-1 secretion by intestinal L-cells may offer a promising alternative for developing new treatments for Type 2 diabetes and obesity
In addition to their roles in neurotransmitter metabolism, MAOs are also involved in the metabolism of certain drugs and biogenic amines
A clinical trial showed that weight loss associated with oral semaglutide (25mg) remained consistent (roughly around 15-18%) across all menopause stages (premenopausal, perimenopausal, and postmenopausal)